NanoViricides, Inc. (NYSE American: NNVC), based in Shelton, Connecticut, has announced a significant step in its clinical development pipeline by engaging a Clinical Research Organization...
Clinical Trials
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing novel therapies for psychiatric disorders, has recently received a Notice of Allowance from the...
